Results 91 to 100 of about 35,769 (259)

Sustained levels of FGF2 are achieved using PLGA microspheres.

open access: yes, 2013
(A) A FACS based assay was used to measure FGF2 levels in culture. This method was sensitive at a range of concentrations and specific to FGF2. On the y-axis is Mean Fluorescence Intensity (MFI), the x-axis is concentrations of FGF2.
Ravi S. Kane (378375)   +11 more
core   +1 more source

Transcriptomic signatures reveal systemic adaptations and immune modulation in response to training and competitive racing in horses

open access: yesEquine Veterinary Journal, EarlyView.
Abstract Background The molecular mechanisms underlying adaptation to physical exertion and racing stress in horses remain incompletely understood. Peripheral blood transcriptomics offers a minimally invasive method to monitor systemic responses to exercise and identify biomarkers of adaptation or overload. Objectives To evaluate transcriptomic changes
Izabela Dąbrowska   +4 more
wiley   +1 more source

Molecular analysis of phosphorylation-dependent secretion of FGF2

open access: yes, 2013
Fibroblast Growth Factor 2 (FGF2) is a potent mitogen with a prominent role in tumor-induced angiogenesis. In addition, FGF2 exerts both direct and indirect effects at the interface between angiogenesis and inflammatory processes as well as functions as ...
Laußmann, Mareike
core   +1 more source

Enrichment of Hyaluronic Acid Binding Tumor Cells by Modulation of Selective Adhesion on Microgel Surfaces

open access: yesMacromolecular Rapid Communications, EarlyView.
We have developed a thermoresponsive microgel system for the selective enrichment of hyaluronic acid‐binding tumor cells. By modulating the adhesion on the microgel surface via temperature changes from 37°C to 30°C, we demonstrate a novel proof‐of‐principle for separating these tumor cell from white blood cells, which has potential applications in ...
Melanie Schmidt   +8 more
wiley   +1 more source

FGF2 cooperates with IL-17 to promote autoimmune inflammation

open access: yes, 2017
IL-17 is a pro-inflammatory cytokine implicated a variety of autoimmune diseases. We have recently reported that FGF2 cooperates with IL-17 to protect intestinal epithelium during dextran sodium sulfate (DSS)-induced colitis. Here, we report a pathogenic
Xinrui Shao   +10 more
core   +2 more sources

MIfEprIstoNE INhIBIts MpA-AND fGf2-INDuCED MAMMAry tuMor Growth But Not fGf2-INDuCED MAMMAry hypErplAsIA

open access: yes, 2020
We have previously demonstrated a crosstalk between fibroblast growth factor 2 (FGF2) and progestins inducing experimental breast cancer growth. The aim of the present study was to compare the effects of FGF2 and of medroxyprogesterone acetate (MPA) on ...
Alfredo Molinolo   +8 more
core  

Osteoarthritis: An Immuno‐Inflammatory Disease‐Mechanisms of Immune Cell Dysregulation and Potential Therapeutic Strategies

open access: yesMed Research, EarlyView.
This review summarizes the immuno‐inflammatory mechanisms driving the pathogenesis of osteoarthritis (OA), extending beyond the traditional view of OA as a purely degenerative disease to incorporate immune cell infiltration, inflammatory factor release, and the formation of a chronic low‐grade inflammatory microenvironment.
Qingqiang Lei   +9 more
wiley   +1 more source

Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents.: FGF2 Inhibition in Pulmonary Hypertension

open access: yes, 2009
12 pagesInternational audiencePulmonary hypertension (PH) is a progressive, lethal lung disease characterized by pulmonary artery SMC (PA-SMC) hyperplasia leading to right-sided heart failure.
Guignabert, Christophe   +23 more
core   +1 more source

PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination

open access: yesNeurobiology of Disease, 2005
Repair of myelin damage in the adult CNS requires oligodendrocyte progenitor (OP) proliferation and subsequent differentiation into remyelinating oligodendrocytes.
Joshua C. Murtie   +4 more
doaj   +1 more source

Cuproptosis Inducers in Cancer Therapy: State of the Art and Challenges

open access: yesThe Chemical Record, EarlyView.
Cuproptosis is emerging as a distinct copper‐dependent cell death pathway, highlighting copper as a potential metabolic vulnerability in cancer. This review examines how coordination chemistry, redox regulation, and nanomaterial design shape Cu reactivity and therapeutic outcomes.
Chiara Ragusa, Valentina Oliveri
wiley   +1 more source

Home - About - Disclaimer - Privacy